MedCap AB (MCAP.XSTO) Dividend Analysis
This company has no dividend history.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
No dividend history found in company filings.
Does MedCap AB (MCAP.XSTO) pay a dividend?
MedCap AB (MCAP.XSTO) has never paid a dividend. It returns cash through buybacks instead, at roughly a 0.3% buyback yield over the last twelve months. The business does generate free cash flow of SEK 321 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does MedCap AB (MCAP.XSTO) pay a dividend?+
No. MedCap AB (MCAP.XSTO) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.
How does MedCap AB return cash to shareholders?+
Through share buybacks rather than dividends. Over the last twelve months MedCap AB reduced its share count at a rate equivalent to a 0.3% buyback yield. A buyback returns value by shrinking the share count, so each remaining share owns more of the business, but unlike a dividend it pays you nothing in cash and can be stopped at any time without an announcement.
Could MedCap AB afford to pay a dividend?+
On the numbers, yes. MedCap AB generated SEK 321 million of free cash flow, which is about SEK 21.44 per share. If it paid out half of that, the dividend would be roughly SEK 10.72 per share, a yield of about 22.7% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with MedCap AB.
Related stocks: Medical Devices
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.